4//SEC Filing
Patel Chintu 4
Accession 0001209191-22-016051
CIK 0001723128other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:19 PM ET
Size
6.3 KB
Accession
0001209191-22-016051
Insider Transaction Report
Form 4
Patel Chintu
DirectorCo-CEO
Transactions
- Award
Performance-Based Restricted Stock Units
2022-03-03+1,159,420→ 1,159,420 total→ Class A Common Stock (1,159,420 underlying)
Footnotes (2)
- [F1]Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents a performance-based restricted stock unit grant of 579,710 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001737428
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 9:19 PM ET
- Size
- 6.3 KB